An artificial pancreas is a medical device designed to automate blood glucose management for individuals with diabetes, particularly those with type 1 diabetes. It typically consists of three main components:
- Continuous Glucose Monitor (CGM): This device continuously measures blood glucose levels.
- Insulin Pump: Delivers insulin to the body based on glucose readings.
- Control Algorithm: A computer algorithm that processes data from the CGM and adjusts insulin delivery from the pump to maintain optimal blood glucose levels.
Artificial Pancreas Market Overview
The Global Artificial Pancreas Market size is estimated to reach at a CAGR of 11% during the forecast period (2024-2031).
An artificial pancreas is a medical device designed to automatically monitor blood glucose levels and administer insulin to individuals with diabetes. It is particularly beneficial for those with type 1 diabetes, where the body is unable to produce adequate insulin. The FDA is actively supporting diabetes patients, healthcare providers, medical device manufacturers, and researchers in advancing the development of artificial pancreas technology. The global market for artificial pancreas systems is growing due to the increasing prevalence of diabetes, extensive research and development efforts by industry players, and the rising demand for automated glycemic control solutions.
Request for free sample:https://www.datamintelligence.com/download-sample/artificial-pancreas-market
Artificial Pancreas Market Dynamics
Technological advancements and rising R&D activities are expected to drive the growth of the artificial pancreas market. The increasing integration of advanced technologies is fueling market expansion, as the demand for Artificial Pancreas Device Systems (APDS) grows. These systems aim to replicate the function of a healthy pancreas, prompting vendors to focus on sophisticated technologies. Effective APDS functionality relies on the integration of sensors, software, and algorithms. For example, Medtronic’s MiniMed 530G system utilizes SmartGuard Technology to effectively manage glucose levels.
Get your customized report @https://www.datamintelligence.com/customize/artificial-pancreas-market
The Artificial Pancreas Market is segmented
By Type: Threshold Suspend Device Systems, Non-threshold Suspend Devices Systems, Control Range System, Control to Target System
By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa
Artificial Pancreas Companies
· Medtronic PLC
· Johnson & Johnson
· Tandem Diabetes Care, Inc.
· Pancreum, Inc.
· Bigfoot Biomedical, Inc.
· DexCom, Inc.
· Beta Bionics, Inc.
· Admetsys Corp.
· Insulet Corporation
· Defymed
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Contact Person: Sai. K
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. At DataM Intelligence, we leverage our top trademark trends, insights, and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek